searcy law Skip to Content
Contact Form Map & Directions Videos

Search Results: hip implant

The first federal transvaginal mesh trial against manufacturer C.R. Bard began in July 2013 in Charleston, West Virginia

07/10/2013
Defective Medical Devices
BY

The first federal transvaginal mesh trial that names manufacturer C.R. Bard begins this week in Charleston, West Virginia. Plaintiff Donna Cisson was implanted with the Bard Avaulta Plus Posterior on May 8, 2009 in Toccoa, Georgia. Bard Urological, a division of C.R. Bard, Inc. designed, labeled, manufactured and sold the […]

Read More

FDA, Industry Debates 510(k)

06/18/2013
Defective Medical Devices
BY

The Food and Drug Administration (FDA) held a meeting this week to consider whether the 510(k) approval process for medical devices is keeping the public safe while balancing the need of industry to get innovative products to the market faster and easier. “External stakeholders” were invited and helped set the […]

Read More

Gravity of Rejuvenate Defects Finally Acknowledged

01/17/2013
Blog
BY

Stryker is finally acknowledging that their Rejuvenate and ABG II modular hip product line can cause serious problems in patients – even if they aren’t yet feeling symptoms of metal poisoning or tissue destruction. Since the Rejuvenate product recall on July 4th, Stryker has been telling patients that if you […]

Read More

High Risk Devices Still Not Reclassified

12/13/2012
Articles
BY

By the end of the year, the U.S. Food and Drug Administration (FDA) had stated it would make sure that high-risk medical devices were approved through the most stringent premarket approval (PMA) review process to assure the safety of consumers. But it looks as though that will not happen. High-risk […]

Read More

Hear What Our Clients Have To Say

"Without question, a tier one law firm! I have been extremely pleased with the quality of service and their attention to detail. Everyone has been extraordinarily kind and professional. I highly recommend this fine organization!"
Posted By: Bud Wilder